The global Cardiac Surgery Instrument Market is estimated to be valued at US$ 1.7 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Cardiac surgery instruments such as forceps, clamps, scissors are used for performing various cardiac surgery procedures such as bypass surgery, heart transplant, heart valve repair and replacement. These instruments provide better control and precision for surgeons during surgeries thereby improving success rates of operations. Market key trends: Growing adoption of minimally invasive procedures owing to benefits such as less pain, lesser hospital stay and faster recovery is a major trend fuelling the growth of the cardiac surgery instruments market. Minimally invasive approaches are becoming increasingly popular alternatives to traditional open-heart surgeries. Another key trend is the rising preference for advanced instruments with added functionalities and features such as ergonomic design, finer tips and superior tactile feedback. These enhance the surgeon's control and ease of use during intricate cardiac surgeries. Technological advancements in biomaterials for better biocompatibility and products providing real-time imaging capabilities for better visualization are also gaining traction in the market. Segment Analysis The global cardiac surgery instruments market is segmented by product type, application, end-user, and region. By product type, the market can be categorized into forceps, clip appliers, scissors, needle holders, clamps, and other cardiac surgery instruments. Among these, forceps dominates the market and is expected to continue its dominance over the forecast period. This is attributed to its extensive usage during open-heart surgeries as it enables surgeons to securely hold tissues without damaging them. Key Takeaways The Global Cardiac Surgery Instrument Market Size is expected to witness high growth, exhibiting a CAGR of 13.% over the forecast period, due to increasing number of cardiovascular disease (CVD) cases worldwide. The global Cardiac Surgery Instrument Market size is expected to reach US$ 1.7 Bn in 2023. North America is expected to hold the largest market share over the forecast period owing to the increasing rate of cardiac surgeries due to rising prevalence of cardiovascular diseases. Europe is expected to exhibit the second largest market size over the forecast period due to supportive government initiatives to improve the healthcare infrastructure and technological advancements in cardiac surgeries. Key players operating in the Cardiac Surgery Instrument Market are Medtronic, Edwards Lifesciences, Abbott Laboratories, Boston Scientific, LivaNova, Sorin Group (now part of LivaNova), Terumo Corporation, Getinge AB, CryoLife, MicroPort Scientific Corporation, B. Braun Melsungen AG, Maquet (now part of Getinge AB), W. L. Gore & Associates, Stryker Corporation, and Merit Medical Systems. Medtronic is expected to continue its dominance over the forecast period owing to its robust product portfolio and strong brand presence worldwide. Read more: https://www.ukwebwire.com/cardiac-surgery-instrument-market-insights-trends/
0 Comments
|
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |